|
|
|
Volumn 26, Issue 5 SUPPL. 14, 1999, Pages 21-25
|
|
Overview of posttransplant B-cell lymphoproliferative disorders
a
a
Building 112
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ALPHA2B INTERFERON;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
FOLINIC ACID;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
EPSTEIN BARR VIRUS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LEUKOCYTE TRANSFUSION;
LYMPHOPROLIFERATIVE DISEASE;
ORGAN TRANSPLANTATION;
PATHOGENESIS;
PRIORITY JOURNAL;
RISK FACTOR;
CELL TRANSFORMATION, NEOPLASTIC;
HERPESVIRIDAE INFECTIONS;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOSUPPRESSION;
LYMPHOPROLIFERATIVE DISORDERS;
RISK FACTORS;
TRANSPLANTATION;
TUMOR VIRUS INFECTIONS;
|
|
EID: 0032719112
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (44)
|
|
References (38)
|
